Once a month, Harald Enzmann provides a newsletter on the regulatory decisions of the Committee for Medicinal Products for Human Use (CHMP) on innovative medicines for the treatment of cancer.

Enzmann has been Chairman of the CHMP since 2018 and heads the "EU and International Affairs" staff unit at the BfArM. The CHMP at the European Medicines Agency is made up of scientists from all member states of the EEA.

Newest issue

The newsletter contextualizes the latest developments and decisions and provides links to more detailed information such as the latest EPARs. It is intended as a user-friendly, concise information platform for pharmacologists and oncologists who treat patients, work in research and development or in regulatory affairs, as well as patients and patient representatives.

Previous issues